NLP, AI, Pharma, Healthcare, Llm.
data, described above, become apparent when attempting to identify suitable cohorts for clinical trials. For instance, the granularity of codes may vary, with some being overly inclusive (e.g., G35) while others are excessively specific or even non-existent (e.g., Y93.E2: I). This inconsistency in